War on Malaria

When most people think of disease in Africa, HIV/AIDS typically comes to mind as the most severe problem; however, malaria claims more lives annually and creates a miserable yearly routine for many Africans.  During the rainy season in Malawi, which runs from November to April, many villagers end up contracting malaria multiple times.  It is difficult to find a Malawian family that is untouched by the disease, which is the leading cause of death in the country.  In a “From the Field” article on the Malaria Vaccine Initiative’s website, the Jackson family from Chakwindima, a rural village west of Lilongwe, is profiled.  Despite taking precautions, the Jacksons contracted the disease a total of 14 times between 5 family members over the course of the 2007-2008 malaria season.

“We sleep under bed nets every night,” said Jacques Jackson, 36, the father.  “But we also spend some time in the early evening outside,” a time thick with mosquitoes, which transmit the disease-causing parasite to humans when they bite them.

Mary Jackson, the mother, “prepares food for us and cooks outside.  The children like to be close to their mother, and so they are outside with her.  And maybe they even are bitten when they sleep under the nets, because they often roll right up against the nets, where the mosquitoes can get them.”

http://www.malariavaccine.org/FromthefieldSeptember2008.php

By James Ratemo, jratemo@ke.nationmedia.com
Posted  Wednesday, October 19  2011 at  15:32

In fact, malaria claims close to 800,000 lives annually, most of which are young children living in Sub-Saharan Africa, and costs African countries more than $12 billion in lost GDP.  With staggering figures such as these, it is easy to see how a potential solution to the malaria crisis could change the lives and futures of millions of Africans.  Although malaria vaccines have been in the works for decades, none have come close to the success of the recent Phase III trials of RTS,S, a drug first developed by GlaxoSmithKlein over 25 years ago to be used by the U.S. military.  More recently, the project has been backed by grant monies from the Bill & Melinda Gates Foundation, which is committed to eradicating malaria worldwide.

Preliminary results from Phase III trials of RTS,S, released October 18, 2011, show that it protected nearly half of the children who received it with acceptable safety and tolerability.  Clinical trials will include tests of over 15,000 children and are scheduled to continue through 2014.

To read the entire article:

http://www.nation.co.ke/News/africa/New+vaccine+fights+malaria+better++study+shows/-/1066/1258052/-/item/0/-/frsujp/-/index.html

And check out this video from the Bill & Melinda Gates Foundation, whose $200 million grant is contributing to the development of RTS,S: